Bruker Corporation logo BRKRP - Bruker Corporation

Price: -- --
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 3864.7% above fair value
Current Price $463.98
Bear Case $4.94 98.9% downside ($4.94 - $463.98) / $463.98 = -98.9% 7% stage 1 growth, 11% discount
Fair Value $11.70 97.5% downside ($11.70 - $463.98) / $463.98 = -97.5% 12% stage 1 growth, 11% discount
Bull Case $18.61 96.0% downside ($18.61 - $463.98) / $463.98 = -96.0% 15% stage 1 growth, 11% discount

Adjust Assumptions

11.6%
11.0%
3.0%

Key Value Driver

FCF growth rate (12% base case)

Terminal Value % of EV 40%
Implied Market Multiple 497.6x
Market is pricing in (growth) 53.1% vs our 11.6% base

Plain-Language Summary

Using a two-stage FCF DCF with 12% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $11.70 per share.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions